Antares Pharma, Inc. (ATRS)

SG&A Expense Growth

10.34%

Quarterly · Period ending:

ATRS logo

ATRS SG&A Expense Growth

Latest reported10.34%
ATRS Quarterly SG&A Growth (QoQ) (0.00% → 10.34%)
High-resolution chart · PNG

ATRS sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
11.6671%
2.345%
16.6667%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.